Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Konsta Kukkonen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, 33520 Tampere, Finland. Hauptthemen laut MEDLINE: Receptors, Androgen, Epithelial Cells, Chromatin, Prostate. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Sigrid Jusélius Foundation, Cancer Foundation Finland.
Abstract (Originalsprache)
Androgen receptor (AR) activation alters chromatin structure in prostate cancer (PC) cells, but its impact in nonmalignant prostate epithelial cells (NPEC) remains poorly characterized due to lack of representative models. We leveraged our previously established NPEC (RWPE-1-AR and RWPE-1-Ctrl) and PC (LNCaP-pcDNA3.1 and LNCaP-ARhi) cell models to profile androgen-driven chromatin responses using assay for transposase-accessible chromatin with sequencing (ATAC-seq). In the absence of androgen, NPEC and PC cells exhibited widespread differences in chromatin accessibility. Androgen stimulation amplified these differences, revealing distinct AR-mediated chromatin remodeling between the cell types. Androgen-sensitive regions were enriched for nuclear receptor binding sites (AR and glucocorticoid receptor), with AP-1 motifs more prominent in NPEC and FOXA1 motifs in PC cells. Comparison with ATAC-seq profiles obtained from clinical samples showed that NPECs resembled benign prostate hyperplasia, while PC cells mirrored untreated and castration-resistant PC, supporting the relevance of our models. Integration of ATAC-seq and mRNA-sequencing (mRNA-seq) identified model-specific AR target genes, including CDKN1C/p57 in NPEC, which may contribute to the previously observed androgen-induced growth arrest in these cells. These findings demonstrate that AR activation reprograms chromatin accessibility in normal prostate epithelium, revealing fundamental regulatory differences compared to the tumor context and underscore the importance of physiologically relevant cell models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, 33520 Tampere, Finland.
- Foundation for the Finnish Cancer Institute, 00290 Helsinki, Finland.
- Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway.
- Institute of Biomedicine, University of Eastern Finland, 70211 Kuopio, Finland.
- Fimlab Laboratories Ltd, Tampere University Hospital, 33520 Tampere, Finland.
ORCID-Profile: Konsta Kukkonen, Ebrahim Afyounian, Hanna Rauhala, Matti Nykter, Alfonso Urbanucci, Leena Latonen, Tapio Visakorpi
Förderung
- Research Council of Finland
- Sigrid Jusélius Foundation
- Cancer Foundation Finland
- Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital
- Finnish Cultural Foundation
- Norwegian Cancer Society
- Tampere Institute for Advanced Study and Cancer Society of Finland
- Tampere University
Zitieren
APA
Kukkonen, K., Afyounian, E., Rauhala, H., Nykter, M., Urbanucci, A., Latonen, L., & Visakorpi, T. (2026). Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag891
Vancouver
Kukkonen K, Afyounian E, Rauhala H, Nykter M, Urbanucci A, Latonen L, et al. Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag891
BibTeX
@article{Kukkonen2026,
author = {Kukkonen, Konsta and Afyounian, Ebrahim and Rauhala, Hanna and Nykter, Matti and Urbanucci, Alfonso and Latonen, Leena and Visakorpi, Tapio},
title = {Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag891}
}
EUVIMED